MNDL Bio's solution focuses on optimizing gene expression in cells to significantly increase protein production yield. Leveraging cutting-edge technology, including advanced algorithms and patented methods, the core technology utilizes Artificial Intelligence (AI) and Machine Learning (ML) based on genomic Big Data.
MNDL enhances the efficiency of biological systems, making them more productive and cost-effective. This has far-reaching applications across various sectors.
The company won the "Coller Startup Competition" for Edition 2023.
Cumulative Funding Raised Over Time ($)
Employees Over Time
MNDL Bio Climate Tech relevance
MNDL Bio's solution is highly relevant in the field of climate tech and holds immense potential for reducing greenhouse gas emissions and promoting environmental sustainability: 1.Promoting Alternative Protein Sources: MNDL Bio facilitates cost-effective and scalable production of alternative proteins. This includes lab-grown meat and plant-based or microbial protein sources, which have significantly lower carbon footprints compared to traditional animal agriculture; 2.Precision Fermentation: Precision fermentation utilizes microbes to produce valuable compounds such as animal-free dairy proteins and sustainable biofuels. By enhancing process efficiency and yield, MNDL Bio contributes to the development of more sustainable production methods; 3.Bio-Based Materials: Synthetic biology offers opportunities for producing bio-based materials like bioplastics, which serve as sustainable alternatives to petroleum-based materials.
Latest News
No Data, yet.
Sorry, no content found under this section.
Apr 27, 2025
www.timesofisrael.com
Intel-backed accelerator kicks off first cohort for Ignite startup program in Israel
null
Mar 3, 2025
www.jpost.com
MNDL Bio wins award for the most innovative biotech solution in the Middle East
undefined
Sep 8, 2024
www.calcalistech.com
The company has raised a total of $2 million for its AI-powered gene optimization platform
#Investment #Expand
Sep 7, 2024
www.calcalistech.com
Israel’s MNDL Bio is taking on a $116 billion market | CTech